Proceedings: The Veterans Administration Cooperative Urological Research Group's studies of cancer of the prostate.

Suppr

超能文献

作者信息

Byar D P

出版信息

Cancer. 1973 Nov;32(5):1126-30. doi: 10.1002/1097-0142(197311)32:5<1126::aid-cncr2820320518>3.0.co;2-c.

DOI:10.1002/1097-0142(197311)32:5<1126::aid-cncr2820320518>3.0.co;2-c

PMID:4585929

Abstract

摘要

相似文献

Proceedings: The Veterans Administration Cooperative Urological Research Group's studies of cancer of the prostate.

Cancer. 1973 Nov;32(5):1126-30. doi: 10.1002/1097-0142(197311)32:5<1126::aid-cncr2820320518>3.0.co;2-c.

The Veterans' Administration Cooperative Urological Research Group studies of carcinoma of the prostate: a review.退伍军人管理局合作泌尿外科研究组关于前列腺癌的研究：综述

Cancer Chemother Rep. 1975 Jan-Feb;59(1):225-7.

Treatment of prostatic cancer: studies by the Veterans Administration cooperative urological research group.前列腺癌的治疗：退伍军人管理局泌尿外科合作研究小组的研究

Bull N Y Acad Med. 1972 Jun;48(5):751-66.

Estrogen treatment for cancer of the prostate. Early results with 3 doses of diethylstilbestrol and placebo.雌激素治疗前列腺癌。三种剂量己烯雌酚与安慰剂的早期结果。

Cancer. 1970 Aug;26(2):257-61. doi: 10.1002/1097-0142(197008)26:2<257::aid-cncr2820260203>3.0.co;2-9.

Current status of estrogen therapy for prostatic carcinoma.雌激素治疗前列腺癌的现状

Postgrad Med. 1972 Mar;51(3):140-5. doi: 10.1080/00325481.1972.11698173.

Hormone therapy for prostate cancer: results of the Veterans Administration Cooperative Urological Research Group studies.前列腺癌的激素治疗：退伍军人管理局合作泌尿外科研究组的研究结果。

NCI Monogr. 1988(7):165-70.

An analysis of the effects of changes from the assigned treatment in a clinical trial of treatment for prostatic cancer.一项关于前列腺癌治疗临床试验中偏离指定治疗的影响分析。

J Chronic Dis. 1973 May;26(5):311-24. doi: 10.1016/0021-9681(73)90034-9.

Treatment and survival of patients with cancer of the prostate. The Veterans Administration Co-operative Urological Research Group.

Surg Gynecol Obstet. 1967 May;124(5):1011-7.

Editorial: Stilboestrol for prostatic cancer.社论：己烯雌酚用于前列腺癌治疗

Br Med J. 1974 Jun 8;2(5918):520. doi: 10.1136/bmj.2.5918.520.

Effect of orchiectomy and various doses of stilbestrol on plasma testosterone levels in patients with carcinoma of the prostate.睾丸切除术及不同剂量己烯雌酚对前列腺癌患者血浆睾酮水平的影响。

Surg Forum. 1970;21:540-1.

引用本文的文献

The Pros and Cons of Estrogens in Prostate Cancer: An Update with a Focus on Phytoestrogens.雌激素在前列腺癌中的利弊：聚焦植物雌激素的最新进展

Biomedicines. 2024 Jul 23;12(8):1636. doi: 10.3390/biomedicines12081636.

Targeting estrogen receptor signaling for treating heart failure.针对雌激素受体信号通路治疗心力衰竭。

Heart Fail Rev. 2024 Jan;29(1):125-131. doi: 10.1007/s10741-023-10356-9. Epub 2023 Oct 3.

Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme.经皮雌激素用于前列腺癌的雄激素抑制：随机前列腺腺癌经皮激素（PATCH）试验计划的长期心血管结局。

Lancet. 2021 Feb 13;397(10274):581-591. doi: 10.1016/S0140-6736(21)00100-8.

The resurgence of estrogens in the treatment of castration-resistant prostate cancer.雌激素在去势抵抗性前列腺癌治疗中的再度兴起。

Indian J Urol. 2019 Jul-Sep;35(3):189-196. doi: 10.4103/iju.IJU_56_19.

Cardiovascular toxicities of systemic treatments of prostate cancer: oestrogen to the rescue?前列腺癌全身治疗的心血管毒性：雌激素能否拯救？

Nat Rev Urol. 2017 Sep;14(9):1. doi: 10.1038/nrurol.2017.126. Epub 2017 Aug 8.

Role of free testosterone levels in patients with metastatic castration-resistant prostate cancer receiving second-line therapy.游离睾酮水平在接受二线治疗的转移性去势抵抗性前列腺癌患者中的作用。

Oncol Lett. 2017 Jan;13(1):22-28. doi: 10.3892/ol.2016.5392. Epub 2016 Nov 17.

Importance of Estrogenic Signaling and Its Mediated Receptors in Prostate Cancer.雌激素信号传导及其介导的受体在前列腺癌中的重要性

Int J Mol Sci. 2016 Aug 31;17(9):1434. doi: 10.3390/ijms17091434.

Therapeutic Rationales, Progresses, Failures, and Future Directions for Advanced Prostate Cancer.晚期前列腺癌的治疗原理、进展、失败之处及未来方向

Int J Biol Sci. 2016 Feb 6;12(4):409-26. doi: 10.7150/ijbs.14090. eCollection 2016.

A Randomised Comparison Evaluating Changes in Bone Mineral Density in Advanced Prostate Cancer: Luteinising Hormone-releasing Hormone Agonists Versus Transdermal Oestradiol.一项评估晚期前列腺癌骨矿物质密度变化的随机对照研究：促黄体生成素释放激素激动剂与经皮雌二醇的比较

Eur Urol. 2016 Jun;69(6):1016-25. doi: 10.1016/j.eururo.2015.11.030. Epub 2015 Dec 17.

Contemporary hormone therapy with LHRH agonists for prostate cancer: avoiding osteoporosis and fracture.当代用于前列腺癌的促黄体生成素释放激素激动剂激素疗法：避免骨质疏松和骨折。

Cent European J Urol. 2015;68(2):165-8. doi: 10.5173/ceju.2015.513. Epub 2015 Apr 20.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验